Balyasny Asset Management
AMGN icon

Balyasny Asset Management’s Amgen AMGN Stock Holding History

Balyasny Asset Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.6M Sell
45,900
-45,200
-50% -$15.5M 0.02% 813
2026
Q1 		$32.1M Sell
91,100
-14,400
-14% -$5.13M 0.04% 502
2025
Q4 		$34.5M Buy
105,500
+48,100
+84% +$15.3M 0.04% 477
2025
Q3 		$16.2M Buy
57,400
+23,800
+71% +$6.9M 0.02% 810
2025
Q2 		$9.38M Buy
33,600
+3,800
+13% +$1.08M 0.01% 997
2025
Q1 		$9.28M Buy
29,800
+11,900
+66% +$3.51M 0.02% 952
2024
Q4 		$4.67M Sell
17,900
-13,100
-42% -$3.89M 0.01% 1319
2024
Q3 		$9.99M Sell
31,000
-6,500
-17% -$2.13M 0.02% 955
2024
Q2 		$11.7M Buy
+37,500
New +$11M 0.02% 812
2024
Q1 		– Sell
-8,000
Closed -$2.3M – 2579
2023
Q4 		$2.3M Buy
+8,000
New +$2.18M ﹤0.01% 1408
2023
Q1 		– Sell
-17,300
Closed -$4.54M – 2610
2022
Q4 		$4.54M Hold
17,300
– – 0.01% 1074
2022
Q3 		$3.9M Buy
17,300
+7,600
+78% +$1.84M 0.01% 1145
2022
Q2 		$2.36M Buy
9,700
+7,100
+273% +$1.74M 0.01% 1325
2022
Q1 		$629K Buy
+2,600
New +$597K ﹤0.01% 1759
2021
Q3 		– Sell
-6,100
Closed -$1.49M – 1905
2021
Q2 		$1.49M Buy
+6,100
New +$1.5M 0.01% 1109
2020
Q4 		– Sell
-60,000
Closed -$15.3M – 1296
2020
Q3 		$15.3M Buy
60,000
+20,000
+50% +$4.95M 0.11% 266
2020
Q2 		$9.43M Buy
+40,000
New +$9.13M 0.08% 350
2019
Q2 		– Sell
-72,000
Closed -$13.7M – 1452
2019
Q1 		$13.7M Sell
72,000
-36,000
-33% -$6.87M 0.09% 316
2018
Q4 		$21M Buy
108,000
+55,500
+106% +$10.8M 0.15% 189
2018
Q3 		$10.7M Buy
+52,500
New +$10.3M 0.05% 473
2017
Q3 		– Sell
-175,000
Closed -$30.1M – 1856
2017
Q2 		$30.1M Buy
+175,000
New +$28.5M 0.12% 219
2017
Q1 		– Sell
-45,000
Closed -$6.58M – 1570
2016
Q4 		$6.58M Buy
+45,000
New +$6.77M 0.04% 617

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Balyasny Asset Management's AMGN Position: Q2 2026 in Review

Balyasny Asset Management increased its Amgen (AMGN) stake by 125% in Q2 2026, buying an estimated $3.41M and bringing the position to 17,944 shares worth $6.5M. The position accounts for 0.01% of the portfolio, ranked #1259.

Balyasny Asset Management first reported a position in AMGN in Q3 2014 and has held it in 36 quarters since. The position peaked at $96.1M in Q3 2024. 3,163 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Balyasny Asset Management held 17,944 shares of Amgen worth $6.5M as of Q2 2026.
  • Balyasny Asset Management bought 9,964 Amgen shares in Q2 2026, an estimated $3.41M.
  • Amgen made up 0.01% of Balyasny Asset Management's portfolio in Q2 2026, its #1259 holding.
  • Balyasny Asset Management first reported a position in Amgen in Q3 2014 and has held it in 36 quarters since.
  • Balyasny Asset Management's Amgen position peaked at $96.1M in Q3 2024.
  • 3,163 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.